Phase II study of oral doxifluridine in elderly patients with advanced non-small-cell lung cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 19, Issue 6, 1996, Pages 592-594

  Baldini, E ^a   Tibaldi, C ^a   Pfanner, E ^a   Ricci, S ^a   Falcone, A ^a   Ceribelli, A ^b   Sarcina, R ^c   Comella, G ^d   Gallo Stampino, C ^e   Conte, P F ^a  

^a UNIVERSITY OF PISA   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e ROCHE MILANO RICERCHE   (Italy)

Author keywords

Advanced non small cell lung cancer; Elderly patients; Oral doxifluridine

Indexed keywords

DOXIFLURIDINE; FLUOROPYRIMIDINE DERIVATIVE;

ADVANCED CANCER; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; METASTASIS; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; THORAX RADIOGRAPHY;

ADMINISTRATION, ORAL; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; DIARRHEA; DRUG ADMINISTRATION SCHEDULE; DRUG TOLERANCE; FEASIBILITY STUDIES; FEMALE; FLOXURIDINE; HOME CARE SERVICES; HUMANS; ISOMERISM; LUNG NEOPLASMS; MALE; REMISSION INDUCTION;

EID: 10544228129     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199612000-00013     Document Type: Article

References (7)

1. Jensen OM, Estève J, Moller D, et al. Cancer in the European Community and its member states. Eur J Cancer 1990;26:1167.
2. Armstrong RD, Diasio RB. Selective activation of 5′-deoxy-5-fluorouridine by tumor cells as a basis for improved therapeutic index. Cancer Res 1981;41:4891-4.
3. Bollag W, Hartmann HR. Tumor inhibitory effects of a new fluorouracil derivate: 5′-deoxy-5-fluorouridine. Eur J Cancer 1980;16:427-32.
4. Winkelmann JJ, Alberto P, Mermillod B. Toxicité de la doxi- fluoridine, analogue peu myelosuppresseur du fluoro-uracile. Bull Cancer 1990;77:225-34.
5. Falcone A, Pfanner E, Ricci S, et al. Oral doxifluridine in elderly patients with metastatic colorectal cancer: a multicenter phase II trial. Ann Oncol 1994;5:760-2.
6. Souphet PJ, Chauvin F, Boissel JP, et al. Polychemotherapy in advanced non small cell lung cancer: a meta-analysis. Lancet 1993;342:19-21.
7. Albain KS, Crowley JJ, Le Blanc M, et al. Survival determinants in extensive stage non small cell lung cancer: the South West Oncology Group experience. J Clin Oncol 1991;9:1618-26.